Low Rate of Complications in Nipple-Sparing Mastectomy for Patients with BRCA1 and BRCA2 Mutation

References

• Sharma P , KlempJR , MahnkenJDet al. Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing. Breast Cancer Res. Treat.145, 707–714 (2020).
   Google Scholar
• Kuchenbaecker KB , HopperJL , BarnesDRet al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA317, 2402–2416 (2017).
   PubMed Web of Science ®Google Scholar
• Hartmann LC , LindorNM. The role of risk-reducing surgery in hereditary breast and ovarian cancer. N. Engl. J. Med.374, 454–468 (2016).
   PubMed Web of Science ®Google Scholar
• Couch FJ , HartSN , SharmaPet al. Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. J. Clin. Oncol.33, 304–311 (2015).
   PubMed Web of Science ®Google Scholar
• Franceschini G , LeoneAD , TerribileDet al. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know. Ann. Ital. Chir.90, 1–2 (2019).
   PubMed Web of Science ®Google Scholar
• Metcalfe K , EisenA , SenterLet al. International trends in the uptake of cancer risk reduction strategies in women with BRCA1 or BRCA2 mutation. Br. J. Cancer121(1), 15–21 (2019).
   PubMed Web of Science ®Google Scholar
• Ingham SL , SperrinM , BaildamAet al. Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referral. Breast Cancer Res. Treat.142, 611–618 (2013).
   PubMed Web of Science ®Google Scholar
• Yao K , LiederbachE , TangRet al. Nipple-sparing mastectomy in BRCA1/2 mutation carriers: an interim analysis and review of the literature. Ann. Surg. Oncol.370, 370–376 (2015).
   Google Scholar
• Jakub JW , PeledAW , GrayRJet al. Oncologic safety of prophylactic nipple-sparing mastectomy in a population with BRCA mutations: a multi-institutional study. JAMA Surg.153, 123–129 (2018).
   PubMed Web of Science ®Google Scholar
• O’Connell RL , TasoulisMK , HristovaEet al. Satisfaction with long-term aesthetic and 10 years oncologic outcome following risk-reducing mastectomy and implant-based breast reconstruction with or without nipple preservation. Cancers14, 3607 (2022).
   PubMed Web of Science ®Google Scholar
• Stanek K , ZimovjanovaM , SukPet al. Bilateral prophylactic nipple-sparing mastectomy: analysis of the risk-reducing effect in BRCA1/2 mutation carriers. Aest. Plast. Surg.46, 706–711 (2022).
   PubMed Web of Science ®Google Scholar
• Pierce LJ , PhillipsKA , GriffithKAet al. Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy. Breast Cancer Res. Treat.121, 389–398 (2010).
   PubMed Web of Science ®Google Scholar
• Tung NM , BougheyJC , PierceLJet al. Management of hereditary breast cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology guideline. J. Clin. Oncol.38, 2080–2106 (2020).
   PubMed Web of Science ®Google Scholar
• Fayanju OM , StollCRT , FowlerSet al. Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysis. Ann. Surg.260, 1000–1010 (2014).
   PubMed Web of Science ®Google Scholar
• Teoh V , TasoulisM-K , GuiG. Contralateral prophylactic mastectomy in women with unilateral breast cancer who are genetic carriers, have a strong family history or are just young at presentation. Cancers12, 140 (2020).
   PubMed Web of Science ®Google Scholar
• Smith BL , TangR , RaiUet al. Oncologic safety of nipple-sparing mastectomy in women with breast cancer. J. Am. Coll. Surg.225, 361–365 (2017).
   PubMed Web of Science ®Google Scholar
• Bailey CR , OgbuaguO , BaltodanoPAet al. Quality of life outcomes improve with nipple-sparing mastectomy and breast reconstruction. Plast. Reconstr. Surg.140, 219–226 (2017).
   PubMed Web of Science ®Google Scholar
• Liede A , CaiM , CrouterTFet al. Risk-reducing mastectomy rates in the US: a closer examination of the Angelina Jolie effect. Breast Cancer Res. Treat.171, 435–442 (2018).
   PubMed Web of Science ®Google Scholar
• Grobmyer SR , PedersonHJ , ValenteSA. Evolving indications and long-term oncological outcomes of risk-reducing bilateral nipple-sparing mastectomy. BJS Open3, 169–173 (2018).
   PubMed Web of Science ®Google Scholar
• Frasson AL , LichtenfelsM , de SouzaABet al. Risk-reducing mastectomy: a case series of 124 procedures in Brazilian patients. Breast Cancer Res. Treat.181, 69–75 (2020).
   PubMed Web of Science ®Google Scholar
• Gilbert E , ZaborEC , StempelMet al. Differences among a modern cohort of BRCA mutation carriers choosing bilateral prophylactic mastectomies compared to breast surveillance. Ann. Surg. Oncol.24, 3048–3054 (2017).
   PubMedGoogle Scholar
• Li X , YouR , WangXet al. Effectiveness of prophylactic surgeries in BRCA1 or BRCA2 mutation carriers: a meta-analysis and systematic review. Clin. Cancer Res.22, 3971–3981 (2016).
   PubMed Web of Science ®Google Scholar
• Song Y , BarryWT , SeahDSet al. Patterns of recurrence and metastasis in BRCA1/BRCA2-associated breast cancers. Cancer126, 271–280 (2020).
   PubMed Web of Science ®Google Scholar
• von Minckwitz G , UntchM , BlohmerJUet al. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J. Clin. Oncol.30, 1796–1804 (2012).
   PubMed Web of Science ®Google Scholar
• Tutt ANJ , GarberJE , KaufmannBet al. Adjuvant olaparib for patients with BRCA1 or BRCA2 mutated breast cancer. N. Engl. J. Med.384, 2394–2405 (2021).
   PubMed Web of Science ®Google Scholar
• Casella D , DiTaranto G , MarcascianoMet al. Nipple‐sparing bilateral prophylactic mastectomy and immediate reconstruction with TiLoop® bra mesh in BRCA1/2 mutation carriers: a prospective study of long‐term and patient reported outcomes using the BREAST‐Q. Breast39, 8‐13 (2018).
   PubMed Web of Science ®Google Scholar
• Kim SW , LeeHK , KangSMet al. Shortterm outcomes of immediate breast reconstruction using an implant or tissue expander after mastectomy in breast cancer patients. Breast Cancer23, 279–285 (2016).
   PubMed Web of Science ®Google Scholar
• Cemal Y , AlbornozCR , DisaJJet al. A paradigm shift in U.S. breast reconstruction: Part 2. The influence of changing mastectomy patterns on reconstructive rate and method. Plast. Reconstr. Surg.131, 320–326 (2013).
   PubMed Web of Science ®Google Scholar
• Metcalfe KA , CilTD , SempleJLet al. Long‐term psychosocial functioning in women with bilateral prophylactic mastectomy: does preservation of the nipple‐areolar complex make a difference? Ann. Surg. Oncol. 22, 3324–3330 (2015).
   PubMed Web of Science ®Google Scholar
• Salibian AA , BekiszJM , FreyJDet al. Prophylactic nipple-sparing mastectomy in young previvors: examining decision-making, reconstructive outcomes, and patient satisfaction in BRCA+ patient under 30. Breast J.26, 1–5 (2019).
   Web of Science ®Google Scholar
• Valero MG , MooTA , MuhsenSet al. Use of bilateral prophylactic nipple-sparing mastectomy in patients with high risk of breast cancer. Br. J. Surg.107, 1307–1312 (2020).
   PubMed Web of Science ®Google Scholar
• Leser C , DeutschmannC , DorffnerGet al. Complication rates among women undergoing preventive mastectomy: an Austrian registry. Breast J.26, 1639–1644 (2020).
   PubMed Web of Science ®Google Scholar
• Manning A , WoodC , StempelMet al. Nipple-sparing mastectomy in patients with BRCA ½ mutations and variants of uncertain significance. Br. J. Surg.102, 1354–1359 (2015).
   PubMed Web of Science ®Google Scholar
• Lin P-H , ChenS-C , TsengL-Met al. Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients. Breast Cancer Res. Treat.192(3), 629–637 (2022).
   PubMed Web of Science ®Google Scholar
• Bernstein-Molho R , LaitmanY , GalperSet al. Locoregional treatments and ipsilateral breast cancer recurrence rates in BRCA1/2 mutation carriers. Int. J. Radiat. Oncol. Biol. Phys.109(5), 1332–1340 (2021).
   Google Scholar
• Rebbeck TR , FriebelT , LynchHTet al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J. Clin. Oncol.22, 1055–1062 (2004).
   PubMed Web of Science ®Google Scholar
• Keller K , MeiselC , GrublingNet al. Patient-reported satisfaction after prophylactic operations of the breast. Breast Care14, 217–223 (2019).
   PubMed Web of Science ®Google Scholar